Dr. Michele Ross, Leading Cannabis Voice, Joins NanoSphere Health Sciences Team

Renowned Advocate and Scientist Takes on Medical Advisor Role for Evolve Formulas

DENVER, June 7, 2018 /PRNewswire/ -- Dr. Michele Ross, neuroscientist, author and cannabinoid medicine leader, has joined the advisory board for NanoSphere Health Sciences, LLC (CSE: NSHS) (OTC: NSHSF), the biotechnology leader behind the patented NanoSphere Delivery System™, which nano-encapsulates cannabinoid molecules in lipid membranes for transportation through the skin into the bloodstream within minutes.

Read More
Samuel TheilComment
NanoSphere Health Sciences and Vertical Companies™ Form Strategic Partnership to Launch Evolve Products in Arizona & California

Licensing agreement will bring the patented NanoSphere Delivery System™ to the world’s largest legal market this summer

DENVER (May 2, 2018)– NanoSphere Health Sciences INC (CSE: NSHS) (OTC: NSHSF), parent company of cannabis brand Evolve Formulas, has joined forces with Vertical™, the largest fully integrated company in the legal medical cannabis industry, to launch Evolve’s growing product line in Arizona and California this summer.

Read More
Samuel TheilComment
Cannabis Breakthrough: Precise Cannabinoid Delivery

Lara Smith

Any marketing guru will tell you that the most successful products are those that precisely meet the user’s needs while making as little fuss as possible. This has been a major issue in the cannabis market since day one because drug delivery methods were developed during an era of prohibition, forcing users to set fire to plants and inhale them in dark corners; hardly

Read More
Samuel TheilComment
NanoSphere's Evolve Formulas Releases CBD Version of Game-Changing NanoSerum™

New product formula utilizes CBD, THC and resveratrol for rapid repair and rejuvenation with nanotechnology for the ultimate therapy 

DENVER, April 30, 2018 /PRNewswire/ -- NanoSphere Health Sciences INC (CSE: NSHS) (OTC: NSHSF), parent company of cannabis brand Evolve Formulas, today announced the latest addition to its cannabis product line-up using NanoSphere Health's patented delivery technology. The new Transdermal NanoSerum™ CBD pen is now available with a desirable 10:1 ratio of CBD:THC. The product will be in Colorado dispensaries starting in mid-May.

Read More
Samuel TheilComment
Letter from Our Chairman

Dear Valued Shareholders,     

I would like to take this opportunity to outline the details of a significant milestone for NanoSphere Health Sciences and how this will impact the future of the company. We have been granted our landmark patent for the NanoSphere Delivery System™, which means we now officially have ownership of the biggest advancement in non-invasive medical delivery in over 25 years. A major thank you is in order to everyone who has come on this journey with us, especially those who have been here since the very beginning—from the challenging years of R&D through the pivotal point of commercialization to now, as we realize this new reality and lay the foundation for the bright future of this business. 

Read More
Samuel TheilComment
NanoSphere Health Sciences Awarded Breakthrough Patent for Disruptive Nanoparticle Delivery Platform

Landmark patent marks most significant advancement in over 25 years for non-invasive medical delivery system

Denver (March 27, 2018) – NanoSphere Health Sciences Inc (CSE: NSHS) (OTC: NSHSF) is pleased to announce that its flagship subsidiary, NanoSphere Health Sciences, LLC, has been granted Patent No. 9,925.149—which covers the core technology behind the production of the NanoSphere Delivery System™—by the United States Patent and Trademark Office.

Read More
President & COO David Sutton interview with Marijuana Times

Tune in to @MarijuanatimesX latest #podcast episode to hear President & COO @davidrsutton discuss the benefits of our delivery system

03-08-2018 Video News – The Marijuana Times Show

Joe Klare discusses final regulations for recreational marijuana in Massachusetts, a case in Texas involving a father giving his autistic daughter medical cannabis and an interview with David Sutton from NanoSphere Health Sciences.

WATCH THE FULL PODCAST HERE

 

Read More
Samuel TheilComment
NanoSphere Health Sciences’ Cannabis Brand Now Available in Over 100 Dispensaries in Colorado

Evolve Formulas’ Transdermal NanoSerum™ Continues to Expand

DENVER (March 7, 2018) – NanoSphere Health Sciences Inc. (CSE: NSHS/ OTC: NSHSF) cannabis product brand Evolve Formulas is now stocked in over 100 dispensaries throughout Colorado. The company’s pioneering product, Transdermal NanoSerum™, uses the NanoSphere Delivery System™ developed by the biotechnology firm to allow cannabis to enter systemic circulation within ten minutes for fast-acting, effective relief from pain, inflammation and anxiety. This milestone comes on the back of continuous growth, with the company recently signing a licensing agreement in California.

Read More
Samuel TheilComment
NanoSphere Health Offers Six-Fold Improvement in Cannabinoid Bioavailability

The U.S. cannabis industry is projected to exceed $50 billion in size over the coming years, according to Cowen & Co., driven by the legalization of adult-use cannabis in California and other states. While there are many opportunities for investors in the space, since they generate high-margin licensing revenue and don’t touch the plant, biotech firms developing innovative delivery mechanisms offer investors a compelling opportunity.

Read More
NanoSphere Health Sciences Presentation Now Available for On-Demand Viewing

NanoSphere Health Sciences Inc., based in Denver, focused on nutraceuticals & supplements, cannabis, pharmaceuticals, OTCs, cosmetics, and animal health products, today announced that the January 18 presentation from Victor Goncalves, Executive Vice President, and Dr. Richard Kaufman, Chief Science Officer, is now available for on-demand viewing at VirtualInvestorConferences.com.

Read More
Samuel TheilComment